Circulating levels of apelin were found to be significantly reduced in patients with HFrEF when compared with those who had HFpEF or had no HF whatsoever, although patients with either abdominal obesity or T2DM have demonstrated elevated levels of the peptide [19,20]. The gene discussed is APLN; the disease is type 2 diabetes mellitus.